Most Read News
- AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex
- Hope builds for a drug that might shut down a variety of cancers
- Bristol-Myers Squibb Foundation marks World Diabetes Day with four grants addressing link between diabetes, depression and distress
- Drug combination therapy causes cancer cells to 'eat themselves'
- Pfizer and GSK to initiate study of novel combination therapy in patients with melanoma
- Bristol-Myers Squibb announces changes in senior management team
- GSK names inaugural winners in unique competition for academic drug hunters
Company Profiles and News
Abbott |
Amgen |
AstraZeneca |
Bayer |
Boehringer Ingelheim |
Bristol-Myers Squibb |
Daiichi Sankyo |
Eli Lilly and Company |
Genzyme |
GlaxoSmithKline |
Lundbeck |
Merck |
Merck KGaA |
Novartis |
Novo Nordisk |
Nycomed |
Pfizer |
Roche |
Sanofi |
Shire |
Takeda |
UCB | ...
Showcase your Company Profile / News
Showcase your Company Profile / News
Pharmaceutical Companies
Be on top of World Pharma News!
Want to place your Ads or News at the top of World Pharma News?
Read more...
Business & Industry News
- New study showed significant reduction in blood glucose with Linagliptin alone and in combination with metformin
- Pfizer acquires Polocard, Poland's leading over-the-counter heart attack prevention brand
- Novartis Foundation launches new leprosy strategy at symposium on disease elimination
- GSK responds to FDA decision on Avandia (rosiglitazone)
- Novartis highlights growth prospects driven by significant R&D pipeline progress and the expected increase in blockbuster treatments
- H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure
- Pfizer and GSK to initiate study of novel combination therapy in patients with melanoma
Research & Development News
- New research shows obesity is an inflammatory disease
- New drug cuts risk of deadly transplant side effect in half
- Human stem cells converted to functional lung cells
- 'Nanosponge vaccine' fights MRSA toxins
- Pills of the future: Nanoparticles
- NIH-funded scientists identify potential target for malaria drugs
- New discoveries in quest for better drugs
Regulatory Affairs News
- FDA requires removal of certain restrictions on the diabetes drug Avandia
- EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
- FDA approves new drug to treat HIV infection
- FDA alerts companies to stop illegal sale of treatments for diabetes
- FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies
- FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers
- FDA budget requests $4.7 billion